Journal List > J Korean Ophthalmol Soc > v.57(9) > 1010391

Kim, Tumurbaatar, Ohn, Ha, and Park: Cerebrospinal Fluid Pressure and Trans-lamina Cribrosa Pressure Difference in Open-angle Glaucoma: KNHANES V

Abstract

Purpose

To investigate the relationships between estimated cerebrospinal fluid pressure (CSFP) and trans-lamina cribrosa pressure difference (TLCPD) in open-angle glaucoma (OAG) in Korean population.

Methods

A total of 10,801 eyes were included from the Korean National Health and Nutrition Examination Survey V. All participants (aged 19 years or older) were classified as non-glaucomatous group, OAG suspect group and OAG group. CSFP was calculated as CSFP (mm Hg) = 0.44 body mass index (kg/m2) + 0.16 diastolic blood pressure (mm Hg) – 0.18 age (years) – 1.91. TLCPD was calculated by subtracting CSFP from intraocular pressure.

Results

The mean estimated CSFP was (8.7 ± 3.3 mm Hg vs. 11.6 ± 3.7 mm Hg, 11.2 ± 3.8 mm Hg vs. 11.6 ± 3.7 mm Hg) was lower, and the mean TLCPD (5.7 ± 4.4 mm Hg vs. 2.2 ± 4.4 mm Hg, 3 ± 4.7 mm Hg vs. 2.2 ± 4.4 mm Hg) was higher in the OAG group and in the OAG suspect group than in the non-glaucomatous control group, respectively (p < 0.001). After adjusting relating factor with CSFP and TLCPD using simple linear regression and multivariate analyses, the mean estimated CSFP was distributed lower (p < 0.001; beta: −0.12; B: −2.306; 95% confidence interval [CI]: −2.717, −1.895) in OAG group than in nonglaucomatous group and the mean TLCPD was distributed higher (p < 0.001; beta: 0.099; B: 1.349; 95% CI: 0.977, 1.72; p < 0.001; beta: 0.118; B: 2.776; 95% CI: 2.264, 3.289) in OAG suspect group and in OAG group than in non-glaucomatous group, respectively.

Conclusions

Estimated CSFP and calculated TLCPD showed essential association with OAG presence. It supports the potential role of low CSFP in the pathogenesis of OAG.

References

1. Crawford Downs J, Roberts MD, Sigal IA. Glaucomatous cupping of the lamina cribrosa: a review of the evidence for active abdominal remodeling as a mechanism. Exp Eye Res. 2011; 93:133–40.
2. Yablonski M, Ritch R, Pokorny KS. Effect of decreased abdominal pressure on optic disk. Invest Ophthalmol Vis Sci. 1979; 18(Suppl):165.
3. Jonas JB, Berenshtein E, Holbach L. Anatomic relationship abdominal lamina cribrosa, intraocular space, and cerebrospinal fluid space. Invest Ophthalmol Vis Sci. 2003; 44:5189–95.
4. Morgan WH, Yu DY, Cooper RL, et al. The influence of abdominal fluid pressure on the lamina cribrosa tissue pressure gradient. Invest Ophthalmol Vis Sci. 1995; 36:1163–72.
5. Morgan WH, Chauhan BC, Yu DY, et al. Optic disc movement with variations in intraocular and cerebrospinal fluid pressure. Invest Ophthalmol Vis Sci. 2002; 43:3236–42.
6. Morgan WH, Yu DY, Alder VA, et al. The correlation between cerebrospinal fluid pressure and retrolaminar tissue pressure. Invest Ophthalmol Vis Sci. 1998; 39:1419–28.
7. Marek B, Harris A, Kanakamedala P, et al. Cerebrospinal fluid pressure and glaucoma: regulation of trans-lamina cribrosa pressure. Br J Ophthalmol. 2014; 98:721–5.
crossref
8. Ren R, Jonas JB, Tian G, et al. Cerebrospinal fluid pressure in abdominal: a prospective study. Ophthalmology. 2010; 117:259–66.
9. Xie X, Zhang X, Fu J, et al. Noninvasive intracranial pressure abdominal by orbital subarachnoid space measurement: the Beijing Intracranial and Intraocular Pressure (iCOP) study. Crit Care. 2013; 17:R162.
10. Jonas JB, Nangia V, Wang N, et al. Trans-lamina cribrosa pressure difference and open-angle glaucoma. The central India eye and medical study. PLoS One. 2013; 8:e82284.
crossref
11. Jonas JB, Wang NL, Wang YX, et al. Estimated trans-lamina cribrosa pressure difference versus intraocular pressure as biomarker for open-angle glaucoma. The Beijing Eye Study 2011. Acta Ophthalmol. 2015; 93:e7–e13.
crossref
12. Wang YX, Jonas JB, Wang N, et al. Intraocular pressure and estimated cerebrospinal fluid pressure. The Beijing Eye Study 2011. PLoS One. 2014; 9:e104267.
crossref
13. Yoon KC, Mun GH, Kim SD, et al. Prevalence of eye diseases in South Korea: data from the Korea National Health and Nutrition Examination Survey 2008–2009. Korean J Ophthalmol. 2011; 25:421–33.
crossref
14. Foster PJ, Buhrmann R, Quigley HA, Johnson GJ. The definition and classification of glaucoma in prevalence surveys. Br J Ophthalmol. 2002; 86:238–42.
crossref
15. Berdahl JP, Allingham RR, Johnson DH. Cerebrospinal fluid pressure is decreased in primary open-angle glaucoma. Ophthalmology. 2008; 115:763–8.
crossref
16. Berdahl JP, Fautsch MP, Stinnett SS, Allingham RR. Intracranial pressure in primary open angle glaucoma, normal tension glaucoma, and ocular hypertension: a case-control study. Invest Ophthalmol Vis Sci. 2008; 49:5412–8.
crossref
17. Guidoboni G, Harris A, Carichino L, et al. Effect of intraocular pressure on the hemodynamics of the central retinal artery: a mathematical model. Math Biosci Eng. 2014; 11:523–46.
crossref
18. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006; 90:262–7.
crossref
19. Kim CS, Seong GJ, Lee NH, et al. Prevalence of primary open-angle glaucoma in central South Korea the Namil study. Ophthalmology. 2011; 118:1024–30.

Figure 1.
Distribution of estimated cerebrospinal fluid pressure. Estimated cerebrospinal fluid pressure (CSFP) was calculated after adjustment for glaucoma status, sex, log-transformed pulse, total cholesterol, log-transformed triglycerides, corneal refractive power, anterior chamber depth, vertical cup-to-ratio, and intraocular pressure.
jkos-57-1392f1.tif
Figure 2.
Distribution of estimated trans-lamina cribrosa pressure difference. Estimated trans-lamina cribrosa pressure difference (TLCPD) was calculated after adjustment for glaucoma status, sex, log-transformed pulse, corneal refractive power, anterior chamber depth, and vertical cup-to-disc ratio.
jkos-57-1392f2.tif
Table 1.
Characteristic per groups
Variable Normal Glaucoma suspect Glaucoma Total Comparison (p-value*)
By patient N = 4,911 N = 895 N = 326 N = 6,132  
 Age (years) 50.8 ± 16.6 54.4 ± 15.7 65.5 ± 11.7 52.1 ± 16.6 <0.0011–2,1–3,2–3
 Sex (n, %)
  Male 1,995 (40.6) 462 (51.6) 152 (46.6) 2,609 (42.5) <0.0011–2
  Female 2,916 (59.4) 433 (48.4) 174 (53.4) 3,523 (57.5)  
 BMI (kg/m2) 23.7 ± 3.4 23.9 ± 3.2 23.7 ± 3.2 23.8 ± 3.4 0.510
 Systolic BP (mm Hg) 119.3 ± 16.9 122.2 ± 18.1 126.6 ± 17.6 120.1 ± 17.2 <0.0011–2,1–3,2–3
 Diastolic BP (mm Hg) 75.6 ± 10.4 76.7 ± 10.3 75.0 ± 10.1 75.7 ± 10.4 0.0041–2,2–3
 Pulse (beats/15 sec) 17.6 ± 2.0 14.1 ± 3.0 17.5 ± 2.1 17.1 ± 2.6 <0.0011–2,2–3
 Total cholesterol (mg/dL) 189.7 ± 36.6 188.1 ± 35.7 190.2 ± 36.2 189.5 ± 36.5 0.468
 HDL cholesterol (mg/dL) 51.8 ± 12.7 50.5 ± 12.6 48.4 ± 11.1 51.5 ± 12.6 <0.0011–2,1–3,2–3
 Triglycerides (mg/dL) 130.5 ± 130.9 137.1 ± 106.7 147.1 ± 81.0 132.3 ± 103.3 0.0101–3
By eye N = 9,149 N = 1,224 N = 428 N = 10,801  
 Corneal refractive power (diopter) −0.8 ± 2.2 −0.7 ± 2.1 −0.7 ± 3.0 −0.8 ± 2.2 0.048
 ACD 2.8 ± 0.5 2.7 ± 0.5 2.7 ± 0.6 2.8 ± 0.5 <0.0011–3
 Vertical CDR 0.3 ± 0.1 0.6 ± 0.1 0.7 ± 0.2 0.4 ± 0.1 <0.0011–2,1–3,2–3
 Horizontal CDR 0.3 ± 0.1 0.6 ± 0.1 0.6 ± 0.2 0.4 ± 0.1 <0.0011–2,1–3,2–3
 Estimated CSFP (mm Hg) 11.6 ± 3.7 11.2 ± 3.8 8.7 ± 3.3 11.4 ± 3.7 <0.0011–2,1–3,2–3
 IOP (mm Hg) 13.7 ± 2.7 14.2 ± 3.0 14.4 ± 3.4 13.8 ± 2.8 <0.0011–2,1–3
 TLCPD (mm Hg) 2.2 ± 4.4 3.0 ± 4.7 5.7 ± 4.4 2.4 ± 4.5 <0.0011–2,1–3,2–3

Values are presented as mean ± SD unless otherwise indicated.

BMI = body mass index; BP = blood pressure; HDL = high-density lipoprotein; ACD = anterior chamber depth; CDR = cup-to-disc ratio; CSFP = cerebrospinal fluid pressure; IOP = intraocular pressure; TLCPD = trans-lamina cribrosa pressure difference.

* p-values were calculated by analysis of variance (ANOVA) assuming unequal variance for continuous variables and Chi-square test for categorical variables. Posthoc comparison by Scheffe's method: i-j means that i-th group had significant differences (i, j = 1, 2, 3; Group 1 = Normal, Group 2 = Glaucoma suspect, Group 3 = Glaucoma).

Table 2.
Linear regression analysis for cerebrospinal fluid pressure
Variable Univariable
Multivariable
B 95% CI Beta p-value B 95% CI Beta p-value VIF
Glaucoma suspect (vs. Normal) −0.348 −0.566, −0.130 −0.030 0.002 0.241 −0.056, 0.538 0.022 0.111 0.000
Galucoma (vs. Normal) −2.871 −3.226, −2.516 −0.151 <0.001 −2.306 −2.717, −1.895 −0.120 <0.001 2.594
Male (ref: Female) 0.869 0.728, 1.009 0.116 <0.001 0.870 0.730, 1.009 0.120 <0.001 1.093
Systolic BP (mm Hg)* −0.140 −0.646, 0.366 −0.005 0.588          
Pulse (beats/15sec)* 1.992 1.514, 2.469 0.082 <0.001 1.502 0.969, 2.035 0.063 <0.001 1.485
Total cholesterol (mg/dL) 0.004 0.002, 0.006 0.041 <0.001 0.003 0.001, 0.005 0.028 0.005 1.162
HDL cholesterol (mg/dL) −0.003 −0.009, 0.002 −0.012 0.228          
Triglycerides (mg/dL)* 0.592 0.472, 0.712 0.095 <0.001 0.599 0.474, 0.724 0.098 <0.001 1.234
Corneal refractive power (diopter) −0.579 −0.609, −0.549 −0.345 <0.001 −0.539 −0.569, −0.509 −0.337 <0.001 1.041
ACD 1.154 1.006, 1.032 0.146 <0.001 0.691 0.548, 0.835 0.089 <0.001 1.027
Vertical CDR −2.578 −3.059, −2.097 −0.101 <0.001 −1.178 −1.832, −0.525 −0.048 <0.001 2.073
Horizontal CDR −2.322 −2.817, −1.826 −0.088 <0.001          
IOP (mm Hg) 0.086 0.061, 0.111 0.065 <0.001 0.034 0.009, 0.059 0.027 0.007 1.110

B = regression coefficient; CI = confidence interval; Beta = standardized regression coefficient; VIF = variance inflation factor; BP = blood pressure; HDL = high-density lipoprotein; ACD = anterior chamber depth; CDR = cup-to-disc ratio; IOP = intracular pressure.

* Natural logarithmic transformations were performed before analysis.

Table 3.
Linear regression analysis trans-lamina cribrosa pressure difference
Variable Univariable
Multivariable
B 95% CI Beta p-value B 95% CI Beta p-value VIF
Glaucoma suspect (vs. Normal) 0.798 0.533, 1.062 0.056 <0.001 1.349 0.977, 1.720 0.099 <0.001 0.000
Galucoma (vs. Normal) 3.537 3.107, 3.967 0.154 <0.001 2.776 2.264, 3.289 0.118 <0.001 2.579
Male (ref: Female) −0.614 −0.785, −0.442 −0.067 <0.001 −0.740 −0.910, −0.570 −0.081 <0.001 1.018
Systolic BP (mm Hg)* 2.257 1.644, 2.869 0.069 <0.001          
Pulse (beats/15 sec)* 2.090 1.509, 2.671 0.070 <0.001 4.604 3.964, 5.243 0.155 <0.001 1.362
Total cholesterol (mg/dL) −0.001 −0.003, 0.002 −0.006 0.538          
HDL cholesterol (mg/dL) −0.008 −0.015, −0.002 −0.024 0.015          
Triglycerides (mg/dL)* −0.100 −0.247, 0.047 −0.013 0.185          
Corneal refractive power (diopter) 0.506 0.468, 0.543 0.248 <0.001 0.492 0.454, 0.530 0.244 <0.001 1.030
ACD −1.134 −1.314, −0.954 −0.118 <0.001 −0.729 −0.909, −0.549 −0.076 <0.001 1.026
Vertical CDR 4.303 3.722, 4.884 0.138 <0.001 2.446 1.623, 3.268 0.080 <0.001 2.090
Horizontal CDR 3.903 3.304, 4.501 0.122 <0.001          

B = regression coefficient; CI = confidence interval; Beta = standardized regression coefficient; VIF = variance inflation factor; BP = blood pressure; HDL = high-density lipoprotein; ACD = anterior chamber depth; CDR = cup-to-disc ratio.

* Natural logarithmic transformations were performed before analysis.

TOOLS
Similar articles